As an actively managed exchange traded fund, the ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG) can more nimbly move into new healthcare frontiers than rival index-based products. Synthetic biology could be a new example of ARKG’s long-running adaptability. Like many of the markets...